iRFCBT: Rumination Focus Cognitive Behavior Therapy

Sponsor
West University of Timisoara (Other)
Overall Status
Unknown status
CT.gov ID
NCT03507114
Collaborator
University of Exeter (Other)
90
1
2
11.1
8.1

Study Details

Study Description

Brief Summary

  1. To investigate the efficacy and acceptability of a guided internet-delivered transdiagnostic intervention targeting repetitive negative thinking for individuals with elevated levels of depression and generalized anxiety disorder (mild to moderate clinical symptoms) vs a wait-list control group (WLCG).

  2. To investigate the hypothesized mechanism of change: Repetitive negative thinking is reduced first, and consequently the clinical symptoms (depression and/or anxiety) decrease.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Rumination-Focused CBT (RFCBT)
N/A

Detailed Description

The effectiveness of a Rumination Focused Cognitive-Behavioral Treatment (RF-CBT) will be compared with a wait list control group using a randomized control trial (RCT) design in a culture where this has not been tested before. The treatment approach was design to specifically target repetitive negative thinking (e.g., rumination and worries). Specifically, the treatment involves first a functional analysis design to help participants identify when rumination starts, distinguish between helpful versus unhelpful repetitive thinking, and learn more functional responses, and experiential and imagery exercises design to help them shift their thought processing towards concreteness, absorption and compassion. The main goal of the study is to test the effectiveness of this transdiagnostic approach in reducing symptom of depression and anxiety.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Folow-up interviews will be carried out by a different team of assessors (blinded to the treatment condition)
Primary Purpose:
Treatment
Official Title:
An Internet-delivered Rumination Focus Cognitive Behavior Therapy in Romania
Actual Study Start Date :
Mar 27, 2018
Anticipated Primary Completion Date :
Jul 30, 2018
Anticipated Study Completion Date :
Feb 27, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Rumination-Focused CBT (RFCBT)

RFCBT seeks to change the process of thinking as opposed to the content of thoughts as in standard CBT. The underlying idea is that shifting individuals repetitive negative thinking into the concrete mode will reduce unconstructive ruminations and worries.

Behavioral: Rumination-Focused CBT (RFCBT)
RFCBT consists of six online modules that include psycho-education, mood diaries, on-line experiential exercises using audio-recordings & vignettes of participants experiences of the therapy.

No Intervention: Wait List Control Group

This arm represents the wait-list comparison group.

Outcome Measures

Primary Outcome Measures

  1. Rumination Response Scale -10 items (RRS10) [Absolute values (average score) of RRS10 subscales (Reflection and Brooding) at 8 weeks (post-intervention)]

    The Rumination Response Scale -10 items (RRS10) was designed to measure participant's level of rumination. The scale has two subscale: Reflection (5 items) and Brooding (5 items). The score for each subscale ranges from 5 to 20, while the total score ranges from 10 to 40. Low scores are associated with low levels of rumination, while high scores are associated with high levels of rumination.

  2. Perseverative Thinking Questionnaire (PTQ) [Absolute values (average score) of PTQ at 8 weeks (post-intervention)]

    Perseverative Thinking Questionnaire (PTQ) was designed to measure participant's level of rumination. The scale is unidimensional and the total score ranges from 0 to 60. Low scores are associated with low levels of rumination, while high scores are associated with high levels of rumination.

  3. Patient Health Questionnaire 9 (PHQ9) [Absolute values (average score) of PHQ9 at 8 weeks (post-intervention)]

    The Patient Health Questionnaire 9 (PHQ9) was designed to measure participant's level of depression. The scale is unidimensional and the total score ranges from 0 to 27. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

  4. Generalized Anxiety Disorder 7 (GAD7) [Absolute values (average score) of GAD7 at 8 weeks (post-intervention)]

    Generalized Anxiety Disorder 7 (GAD7) was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score ranges from 0 to 21. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.

  5. Social Phobia Inventory (SPIN) [Absolute values (average score) of SPIN at 8 weeks (post-intervention)]

    The SPIN was designed to measure participant's level of social phobia. The scale is unidimensional and the total score ranges from 0 to 68. Low scores are associated with low levels of social phobia, while high scores are associated with high levels of social phobia.

  6. Anxiety Sensitivity Index 16 (ASI16) [Absolute values (average score) of ASI at 8 weeks (post-intervention)]

    ASI16 was designed to measure participant's level of anxiety sensitivity. The scale is unidimensional and the total score ranges from 0 to 64. Low scores are associated with low levels of anxiety sensitivity, while high scores are associated with high levels of anxiety sensitivity.

Secondary Outcome Measures

  1. Work and Social Adjustment Scale (WSAS) [Absolute values (average score) of WSAS at 8 weeks (post-intervention)]

    Work and Social Adjustment Scale (WSAS) was designed to measure symptom interference. The scale is unidimensional and the total score ranges from 0 to 40. Low scores are associated with higher levels of functioning (less interference of clinical symptoms) while high scores are associated with lower levels of functioning (or high interference of clinical symptoms).

  2. Beck Depression Inventory-II (BDI-II) [Absolute values (average score) of BDI-II at 8 weeks (post-intervention)]

    The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score ranges from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

  3. Penn State Worry Questionnaire (PSWQ) [Absolute values (average score) of PSWQ at 8 weeks (post-intervention)]

    The PSWQ was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score ranges from 16 to 80. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. be fluent in Romanian,

  2. be at least 18 years of age,

  3. display elevated levels of worry and/or rumination (e.g., at least one self-report score above the following cut-offs: Penn State Worry Questionnaire Total score > 50 and/or Rumination Response Scale - Brooding sub-scale ≥ 10)

  4. have at least a clinical diagnosis of major depressive disorder/dysthymia, and/or generalized anxiety disorder, and/or social anxiety disorder, and/or panic disorder, or any combination of these conditions on Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders (SCID-I)

Exclusion Criteria:
  1. suicidal plans,

  2. changes in the dosage if psychotropic medication during the last month (if present),

  3. have bipolar disorder or psychosis (according to medication status)

  4. have an alcohol/substance abuse and/or dependence disorder

  5. currently take part in other psychological treatment,

  6. obvious obstacle to participation (i.e., no current Internet access, long travel plans during the treatment period etc.);

  7. have a primary diagnostic of Post-Traumatic Stress Disorder and/or Obsessive Compulsive Disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 West University of Timisoara Timișoara Timiș Romania 300223

Sponsors and Collaborators

  • West University of Timisoara
  • University of Exeter

Investigators

  • Study Director: Bogdan Tudor Tulbure, PhD, West University of Timisoara

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
West University of Timisoara
ClinicalTrials.gov Identifier:
NCT03507114
Other Study ID Numbers:
  • WUTimisoara-iRFCBT
First Posted:
Apr 24, 2018
Last Update Posted:
Apr 27, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by West University of Timisoara
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2018